JENNA RING: Open Payments
NPI 1124463500 · SALAMANCA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 38 payments from 11 companies in 2025. Trend: 2023 $300 · 2024 $516 · 2025 $760
Food & beverage: $760
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $157 |
| GlaxoSmithKline, LLC. | 9 | $144 |
| Otsuka America Pharmaceutical, Inc. | 5 | $104 |
| Lilly USA, LLC | 5 | $92 |
| Novo Nordisk Inc | 3 | $80 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| Lundbeck LLC | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| ABBVIE INC. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $22 |
Products named: TRELEGY ELLIPTA, FARXIGA, REXULTI, JARDIANCE, CAPLYTA, Ozempic, AIRSUPRA, Wegovy.
Industry payments across NY — which companies pay providers there.
